CN105802983A - High-flux screening method of aliphatic hydrocarbon generation gene, obtained mutant and application - Google Patents
High-flux screening method of aliphatic hydrocarbon generation gene, obtained mutant and application Download PDFInfo
- Publication number
- CN105802983A CN105802983A CN201610183720.5A CN201610183720A CN105802983A CN 105802983 A CN105802983 A CN 105802983A CN 201610183720 A CN201610183720 A CN 201610183720A CN 105802983 A CN105802983 A CN 105802983A
- Authority
- CN
- China
- Prior art keywords
- aliphatic hydrocarbon
- mutant
- gene
- detecting element
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/02—Preparation of hydrocarbons or halogenated hydrocarbons acyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/0108—Long-chain acyl-[acyl-carrier-protein] reductase (1.2.1.80)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种产脂肪烃基因的高通量筛选方法及获得的突变体与应用,属于生物工程技术领域。The invention relates to a high-throughput screening method for aliphatic hydrocarbon-producing genes, the obtained mutant and its application, and belongs to the technical field of bioengineering.
背景技术Background technique
发展生物燃料是解决人类所面临的资源、能源与环境等方面问题的有效途径之一。由于脂肪烃是汽油、柴油、航空煤油等发动机燃料的主要成分,具有高能量密度、低吸湿性与低挥发性,并且与现有运输设施及发动机系统相匹配,生物脂肪烃已经被认为是一种最有潜力的优质生物燃料。The development of biofuels is one of the effective ways to solve the problems of resources, energy and environment faced by human beings. Since aliphatic hydrocarbons are the main components of gasoline, diesel, aviation kerosene and other engine fuels, they have high energy density, low hygroscopicity and low volatility, and are compatible with existing transportation facilities and engine systems, bio-aliphatic hydrocarbons have been considered as a The most promising high-quality biofuel.
近年来,在一些生物体中陆续发现,某些特定的酶能够将细胞内的脂肪族化合物(如脂肪酸、脂肪醛)转化为脂肪烃。例如,在蓝细菌中主要存在一条两步法合成脂肪烃的途径,即脂酰ACP在脂酰ACP还原酶(AAR)作用下生成脂肪醛,脂肪醛再经脂肪醛脱甲酰加氧酶(ADO)催化脱甲酰基生成脂肪烃和甲酸。此外,在Jeotgalicoccus菌中存在一种细胞色素P450OleT,它能够直接将脂肪酸脱羧基生成具有末端不饱和双键的烯烃。目前上述途径均已实现在大肠杆菌或蓝细菌中重组表达,且成功检测到C15、C17、C19等脂肪烃的合成,表现出较好的发展前景。In recent years, it has been found in some organisms that some specific enzymes can convert intracellular aliphatic compounds (such as fatty acids and fatty aldehydes) into aliphatic hydrocarbons. For example, in cyanobacteria, there is mainly a two-step pathway for the synthesis of aliphatic hydrocarbons, that is, fatty acyl-ACP generates fatty aldehyde under the action of fatty-acyl-ACP reductase (AAR), and fatty aldehyde is then processed by fatty aldehyde deformyloxygenase ( ADO) catalyzed reformylation to aliphatic hydrocarbons and formic acid. In addition, there is a cytochrome P450OleT in Jeotgalicoccus bacteria, which can directly decarboxylate fatty acids to olefins with terminal unsaturated double bonds. At present, the above-mentioned pathways have been recombinantly expressed in Escherichia coli or cyanobacteria, and the synthesis of aliphatic hydrocarbons such as C15, C17, and C19 has been successfully detected, showing a good development prospect.
目前一些具有天然脂肪烃生物合成途径的微生物合成脂肪烃的效率都很低,并不具备工业应用潜力,一个关键原因在于催化剂极低的催化效率。因此,通过生物工程技术手段提高上述脂肪烃合成途径中关键酶的催化活性,是促进脂肪烃生物合成的有效途径之一。例如通过向酶的一级结构中随机或半随机地引入单个或数个氨基酸的插入、删除或替换,通过相应的高通量筛选方法,是改变酶的催化特性,实现酶的改良的一种有效手段。由于潜在可选的改造方案众多,如何通过高通量筛选手段快速分离出产烃能力强的酶或突变株,是目前亟待解决的问题。然而,受脂肪烃自身的物理化学性质限制,如何快速评价微生物合成脂肪烃的能力是研究工作中的难点。传统的技术流程是首先通过有机溶剂将细胞中的脂肪烃抽提和浓缩,然后通过气相色谱-质谱联用技术分析其中脂肪烃组分的含量,分析过程通量低,所需时间长,分析成本较高(SchirmerA,etal,Science,2010.329:559-562)。受分析方法的限制,目前尚无针对产脂肪烃基因的高通量筛选方法的实施先例。At present, some microorganisms with natural aliphatic hydrocarbon biosynthesis pathways have low efficiency in synthesizing aliphatic hydrocarbons and do not have the potential for industrial application. One key reason is the extremely low catalytic efficiency of catalysts. Therefore, improving the catalytic activity of key enzymes in the aliphatic hydrocarbon synthesis pathway through bioengineering technology is one of the effective ways to promote the biosynthesis of aliphatic hydrocarbons. For example, by randomly or semi-randomly introducing single or several amino acid insertions, deletions or substitutions into the primary structure of the enzyme, and through corresponding high-throughput screening methods, it is a method to change the catalytic properties of the enzyme and realize the improvement of the enzyme. effective means. Due to the large number of potential modification schemes, how to quickly isolate enzymes or mutants with strong hydrocarbon production ability through high-throughput screening methods is an urgent problem to be solved. However, limited by the physical and chemical properties of aliphatic hydrocarbons, how to quickly evaluate the ability of microorganisms to synthesize aliphatic hydrocarbons is a difficult point in research work. The traditional technical process is to first extract and concentrate the aliphatic hydrocarbons in the cells through organic solvents, and then analyze the content of aliphatic hydrocarbons in them by gas chromatography-mass spectrometry. The analysis process has low throughput and takes a long time. Higher cost (SchirmerA, et al, Science, 2010.329:559-562). Limited by the analysis method, there is no precedent for the implementation of a high-throughput screening method for aliphatic hydrocarbon-producing genes.
发明内容Contents of the invention
为解决上述问题,本发明提供了一种产脂肪烃基因的高通量筛选方法及获得的突变体与应用,所采取的技术方案如下:In order to solve the above problems, the present invention provides a high-throughput screening method for producing aliphatic hydrocarbon genes and the obtained mutants and applications. The technical scheme adopted is as follows:
本发明的目的在于提供一种产脂肪烃基因的高通量筛选方法,该方法是将携带潜在产脂肪烃基因的载体导入到携带有检测元件的宿主细胞中,培养宿主细胞,通过对检测元件信号响应鉴别目的基因的表达情况,并分离高产脂肪烃的突变体。The object of the present invention is to provide a high-throughput screening method for aliphatic hydrocarbon-producing genes. The method is to introduce a vector carrying a potential aliphatic hydrocarbon-producing gene into a host cell carrying a detection element, cultivate the host cell, and pass the detection element Signal Response Identify the expression profile of the gene of interest and isolate mutants that produce high aliphatic hydrocarbons.
所述筛选方法的步骤如下:The steps of the screening method are as follows:
1)扩增产脂肪烃基因,并通过易错PCR反应引入随机突变,获得扩增产物;1) amplify the aliphatic hydrocarbon gene, and introduce random mutation through error-prone PCR reaction to obtain the amplified product;
2)将步骤1)获得的扩增产物经酶切后连接到含有抗性基因的质粒载体中,获得重组质粒;2) connecting the amplified product obtained in step 1) to a plasmid vector containing a resistance gene after digestion to obtain a recombinant plasmid;
3)构建携带检测元件的宿主细胞,并将步骤2)所得的重组质粒转化至宿主细胞,获得转化子;3) constructing a host cell carrying the detection element, and transforming the recombinant plasmid obtained in step 2) into the host cell to obtain a transformant;
4)培养步骤3)所得转化子,检测并根据对检测元件的信号响应进行目的基因表达的鉴定并分离高产脂肪烃的突变体。4) Cultivate the transformant obtained in step 3), detect and identify the expression of the target gene according to the signal response to the detection element and isolate the mutant with high aliphatic hydrocarbon production.
优选地,步骤1)所述产脂肪烃基因,是脂肪醛脱甲酰加氧酶基因ADO。Preferably, the aliphatic hydrocarbon-producing gene in step 1) is the fatty aldehyde deformyloxygenase gene ADO.
优选地,步骤3)所述检测元件,包括脂肪烃检测元件和报告元件。Preferably, the detection element in step 3) includes an aliphatic hydrocarbon detection element and a reporting element.
更优选地,所述脂肪烃检测元件,至少包含一个组成型启动子、一个转录激活因子和一个烃响应特性启动子;所述报告元件,是绿色荧光蛋白、LacZ基因、荧光素酶或抗性基因中的一种。More preferably, the aliphatic hydrocarbon detection element at least comprises a constitutive promoter, a transcriptional activator and a hydrocarbon-responsive promoter; the reporter element is green fluorescent protein, LacZ gene, luciferase or resistance one of the genes.
优选地,所述组成型启动子为启动子PalkS,其核苷酸序列如SEQIDNO.6所示;所述转录激活因子,为转录激活因子AlkR,氨基酸序列如SEQIDNO.7所示;所述烃响应特性启动子,是启动子PalkM,核苷酸序列如SEQIDNO.8所示。Preferably, the constitutive promoter is the promoter PalkS, whose nucleotide sequence is shown in SEQ ID NO.6; the transcription activator is a transcription activator AlkR, whose amino acid sequence is shown in SEQ ID NO.7; the hydrocarbon The responsive characteristic promoter is the promoter PalkM, and its nucleotide sequence is shown in SEQ ID NO.8.
优选地,步骤3)所述宿主细胞,是大肠杆菌、酵母或蓝细菌。Preferably, the host cell in step 3) is Escherichia coli, yeast or cyanobacteria.
优选地,步骤4)所述检测元件的信号,是指荧光强度、光吸收值、化学发光强度和菌落大小中的一种或几种。Preferably, the signal of the detection element in step 4) refers to one or more of fluorescence intensity, light absorption value, chemiluminescence intensity and colony size.
所述任一筛选方法在高产脂肪烃基因工程菌中的应用。Application of any of the screening methods in high-yield aliphatic hydrocarbon genetically engineered bacteria.
本发明的另一目的在于提供一种利用所述筛选方法获得的突变体,该突变体如SEQIDNO.1所示的脂肪醛脱甲酰加氧酶的氨基酸序列至少发生以下一种变化:Another object of the present invention is to provide a mutant obtained by the screening method, the mutant has at least one of the following changes in the amino acid sequence of the fatty aldehyde deformyloxygenase shown in SEQ ID NO.1:
1)第194位谷氨酸突变为亮氨酸(E194K),其氨基酸序列如SEQIDNO.2所示;1) The 194th glutamic acid is mutated to leucine (E194K), and its amino acid sequence is shown in SEQ ID NO.2;
2)第9位谷氨酸突变为甘氨酸,且第27位异亮氨酸突变为天冬酰胺(I9G&I27N),其氨基酸序列如SEQIDNO.3所示;2) The 9th glutamic acid is mutated to glycine, and the 27th isoleucine is mutated to asparagine (I9G&I27N), the amino acid sequence of which is shown in SEQ ID NO.3;
3)第204位谷氨酸突变为苯丙氨酸(I204F),其氨基酸序列如SEQIDNO.4所示。3) The 204th glutamic acid is mutated to phenylalanine (I204F), the amino acid sequence of which is shown in SEQ ID NO.4.
所述突变体在脂肪烃生物合成中的应用也在本发明的保护范围之内。The application of the mutants in the biosynthesis of aliphatic hydrocarbons is also within the protection scope of the present invention.
本发明获得的有益效果是:The beneficial effect that the present invention obtains is:
利用本发明提供的筛选方法获得的脂肪醛脱甲酰加氧酶突变体具有较该酶野生型具有更高的脂肪烃合成效率;本发明提供的高产脂肪烃基因的高通量筛选方法有助于快速的从具有潜在产烃能力的备选基因及其突变体文库中筛选出具有更高产烃效率的特定基因或突变体;具体地:The fatty aldehyde deformyloxygenase mutant obtained by the screening method provided by the invention has higher aliphatic hydrocarbon synthesis efficiency than the enzyme wild type; the high-throughput screening method of high-yield aliphatic hydrocarbon gene provided by the present invention is helpful To quickly screen out specific genes or mutants with higher hydrocarbon production efficiency from candidate genes with potential hydrocarbon production capacity and their mutant library; specifically:
1)本发明所述脂肪醛脱甲酰加氧酶突变基因的突变位点在本发明之前无公开报道。1) There is no public report on the mutation site of the fatty aldehyde deformyloxygenase mutant gene of the present invention before the present invention.
2)本发明所述高通量筛选方法利用脂肪烃检测元件在细胞中直接检测脂肪烃的合成情况,可根据报告蛋白的信号强度(如荧光、化学发光、酶活等),首次实现从较大的基因文库中快速筛选出具有产烃能力以及产烃能力更强的特定基因及其突变体,此前尚无其他类似的针对产脂肪烃基因的高通量筛选方法的报道。2) The high-throughput screening method of the present invention utilizes the aliphatic hydrocarbon detection element to directly detect the synthesis of aliphatic hydrocarbons in cells, which can be used for the first time according to the signal intensity of the reporter protein (such as fluorescence, chemiluminescence, enzyme activity, etc.) Specific genes and their mutants with hydrocarbon-producing ability and stronger hydrocarbon-producing ability can be quickly screened out of a large gene library. There has been no other similar high-throughput screening method for aliphatic hydrocarbon-producing genes.
附图说明Description of drawings
图1携带AAR-ADO产烃基因的质粒1示意图。Fig. 1 is a schematic diagram of plasmid 1 carrying AAR-ADO hydrocarbon-producing gene.
图2大肠杆菌中的脂肪烃的GC-MS检测结果。Figure 2 GC-MS detection results of aliphatic hydrocarbons in Escherichia coli.
其中,图A为对照样品,图B为产脂肪烃的大肠杆菌样品,内标物为正二十烷,主要脂肪烃产物为正十五烷与十七烯。Among them, Figure A is the control sample, Figure B is the aliphatic hydrocarbon-producing Escherichia coli sample, the internal standard is n-eicosane, and the main aliphatic hydrocarbon products are n-pentadecane and heptadecene.
图3携带脂肪烃检测元件的质粒2示意图。Figure 3 is a schematic diagram of plasmid 2 carrying an aliphatic hydrocarbon detection element.
图4菌液荧光强度随诱导剂浓度和培养时间的变化及脂肪烃含量与荧光强度的关系;Fig. 4 bacterium fluid fluorescence intensity changes with inducer concentration and culture time and the relation of aliphatic hydrocarbon content and fluorescence intensity;
其中,图A为菌液荧光强度随诱导剂浓度和培养时间的变化;B为脂肪烃含量与荧光强度的关系。Among them, Figure A is the change of the fluorescence intensity of the bacterial solution with the concentration of the inducer and the culture time; B is the relationship between the aliphatic hydrocarbon content and the fluorescence intensity.
图5本发明提供的高产脂肪烃基因的高通量筛选方法原理示意图。Fig. 5 is a schematic diagram of the principle of the high-throughput screening method for high-yielding aliphatic hydrocarbon genes provided by the present invention.
图6本发明实施例所提供的流式分选结果示意图;Fig. 6 is a schematic diagram of flow sorting results provided by the embodiment of the present invention;
(图中,a为未诱导的细胞流式分析结果;b为0.05mMIPTG诱导的细胞流式分选结果)。(In the figure, a is the result of flow cytometry analysis of uninduced cells; b is the result of flow cytometry of cells induced by 0.05mMIPTG).
图7通过定向进化筛选得到的ADO优势突变体的脂肪烃合成量和相对于野生型的提高水平;The aliphatic hydrocarbon synthesis amount of the ADO dominant mutant obtained by directed evolution screening and the improvement level relative to the wild type in Fig. 7;
(其中,wt:作为突变模板的野生型脂肪醛脱甲酰加氧酶;3-3:ADO突变体I(E194K);5-3:ADO突变体II(E9G&I27N);5-7:ADO突变体III(I204F);3-3/5-3:ADO突变体IV(E194K&E9G&I27N)。(wherein, wt: wild-type fatty aldehyde deformyloxygenase as a mutation template; 3-3: ADO mutant I (E194K); 5-3: ADO mutant II (E9G&I27N); 5-7: ADO mutation Body III (I204F); 3-3/5-3: ADO mutant IV (E194K & E9G & I27N).
具体实施方式detailed description
下面将结合附图和实施例对本发明的实施方案进行详细描述,但是本领域技术人员将理解,下列附图和实施例仅用于说明本发明,而不是对发明的范围的限定。根据附图和优选方法的下列详细描述,本发明的各种目的和有利方面对于本领域技术人员来说将变得显然。Embodiments of the present invention will be described in detail below with reference to the drawings and examples, but those skilled in the art will understand that the following drawings and examples are only for illustrating the present invention, rather than limiting the scope of the invention. Various objects and advantages of this invention will become apparent to those skilled in the art from the accompanying drawings and the following detailed description of a preferred method.
下面将结合实施例对本发明的实施方案进行详细描述。本领域技术人员将会理解,下面的实施例仅用于说明本发明,而不应视为限定本发明的范围。Embodiments of the present invention will be described in detail below in conjunction with examples. Those skilled in the art will understand that the following examples are only for illustrating the present invention and should not be considered as limiting the scope of the present invention.
除非特别指出,否则本发明中所使用的分子生物学试验方法,基本上参照J.Sambroo等人,分子克隆:实验室手册,第2版,冷泉港实验室出版社,1989,以及F.M.Ausubel等人,精编分子生物学实验指南,第3版,JohnWiley&Sons,Inc.,1995中所述的方法进行或者按照产品说明书进行。所用试剂未注明生产厂商者,均为可以通过市购获得的常规产品。本领域技术人员知晓,实施例以举例方式描述本发明,且不意欲限制本发明所要求保护的范围。Unless otherwise indicated, otherwise the molecular biology test method used in the present invention, basically with reference to people such as J.Sambroo, molecular cloning: laboratory handbook, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, and F.M.Ausubel etc. People, Molecular Biology Laboratory Manual, 3rd Edition, John Wiley & Sons, Inc., 1995, performed according to the method described in or according to the product instructions. The reagents used were not indicated by the manufacturer, but were commercially available conventional products. Those skilled in the art understand that the examples describe the present invention by way of example and are not intended to limit the scope of the claimed invention.
序列表信息:Sequence listing information:
SEQIDNO.1:脂肪醛脱甲酰加氧酶ADO的氨基酸序列。SEQ ID NO.1: Amino acid sequence of fatty aldehyde deformyloxygenase ADO.
SEQIDNO.2:ADO突变体II:E194K的氨基酸序列。SEQ ID NO.2: Amino acid sequence of ADO mutant II: E194K.
SEQIDNO.3:ADO突变体I:E9G&I27N的氨基酸序列。SEQ ID NO.3: Amino acid sequence of ADO mutant I: E9G & I27N.
SEQIDNO.4:ADO突变体III:I204F的氨基酸序列。SEQ ID NO.4: Amino acid sequence of ADO mutant III: I204F.
SEQIDNO.5:ADO突变体IV:E9G&I27N&E194K的氨基酸序列SEQ ID NO.5: Amino acid sequence of ADO mutant IV: E9G&I27N&E194K
SEQIDNO.6:组成型启动子PalkS的脱氧核糖核酸序列。SEQ ID NO.6: The deoxyribonucleic acid sequence of the constitutive promoter PalkS.
SEQIDNO.7:编码转录调控因子AlkR的氨基酸序列。SEQ ID NO.7: Amino acid sequence encoding transcription regulator AlkR.
SEQIDNO.8:烃响应启动子PalkM的脱氧核糖核酸序列。SEQ ID NO.8: The deoxyribonucleic acid sequence of the hydrocarbon-responsive promoter PalkM.
SEQIDNO.9:引物ADO-For的核苷酸序列。SEQ ID NO.9: Nucleotide sequence of primer ADO-For.
SEQIDNO.10:引物ADO-Rev的核苷酸序列。SEQ ID NO.10: Nucleotide sequence of primer ADO-Rev.
实施例1大肠杆菌脂肪烃合成途径的构建与脂肪烃含量测定Example 1 Construction of Escherichia coli aliphatic hydrocarbon synthesis pathway and determination of aliphatic hydrocarbon content
菌株:Strains:
大肠杆菌BL21(DE3)ΔfadEEscherichia coli BL21(DE3)ΔfadE
载体:Carrier:
携带脂肪醛脱甲酰加氧酶ADO和脂酰ACP还原酶AAR的质粒1:pACYCduet-ADO-AAR(图1)Plasmid 1 carrying fatty aldehyde deformyloxygenase ADO and fatty acyl-ACP reductase AAR: pACYCduet-ADO-AAR (Figure 1)
培养基:Medium:
LB培养基(含胰蛋白胨10g/L,酵母浸膏粉5g/L,NaCl10g/L,若为固体培养基,则每升培养基添加琼脂15g/L)LB medium (containing tryptone 10g/L, yeast extract powder 5g/L, NaCl10g/L, if it is a solid medium, add agar 15g/L per liter of medium)
改良M9培养基(含6g/LNa2HPO4,3g/LKH2PO4,0.5g/LNaCl,2g/LNH4Cl,0.25g/LMgSO4·7H2O,11mg/LCaCl2,27mg/LFeCl3·6H2O,2mg/LZnCl2·4H2O,2mg/LNa2MoO4·2H2O,1.9mg/LCuSO4·5H2O,0.5mg/LH3BO3,1mg/L维生素B1,200mMBis-Tris(pH7.25)和0.1%(v/v)Triton-X100)Improved M9 medium (containing 6g/LNa 2 HPO 4 , 3g/LKH 2 PO 4 , 0.5g/LNaCl, 2g/LNH 4 Cl, 0.25g/LMgSO 4 7H 2 O, 11mg/LCaCl 2 , 27mg/LFeCl 3 6H 2 O, 2mg/LZnCl 2 4H 2 O, 2mg/LNa 2 MoO 4 2H 2 O, 1.9mg/LCuSO 4 5H 2 O, 0.5mg/LH 3 BO 3 , 1mg/L Vitamin B1, 200mMBis -Tris (pH7.25) and 0.1% (v/v) Triton-X100)
实施步骤:将质粒1转化大肠杆菌BL21(DE3)ΔfadE,将获得的转化子在抗性LB培养基(含34μg/mL氯霉素)中过夜培养后,转接至相应抗性的改良M9培养基,培养至对数期(OD600≈0.6-0.8)后,加入1mMIPTG诱导产烃基因表达,继续培养约20-40小时后,取3~100mL菌液,向其中加入正二十烷标准物至一定浓度(1~50mg/L),并加入与菌液等体积的氯仿:甲醇混合液(氯仿与甲醇按体积比2:1混合)充分震荡,离心(参考离心条件4℃,离心力8000×g,15min)后取下层有机相吹干,加入200~500μL色谱纯正己烷溶解残余油相,离心后将上清转移至色谱进样瓶中并用GC-MS检测样品中的脂肪烃含量。参考色谱检测条件:气相色谱-质谱联用仪(GC-MS)检测采用Agilent7890A-5975C的HP-INNOWax(30m×250μm×0.25μm)色谱柱,采用氦气作为载流气,稳定流速为1mL/min。进样口温度为250℃,风流比为20:1,升温程序为:100℃保持温度1min,然后5℃/min升温到150℃,接着10℃/min升温到250℃,保持温度15min。Implementation steps: transform plasmid 1 into Escherichia coli BL21(DE3)ΔfadE, culture the obtained transformant in resistant LB medium (containing 34 μg/mL chloramphenicol) overnight, and then transfer to the corresponding resistant modified M9 culture After culturing to the logarithmic phase (OD600≈0.6-0.8), add 1 mM IPTG to induce the expression of hydrocarbon-producing genes, continue culturing for about 20-40 hours, take 3-100 mL of bacterial liquid, and add n-eicosane standard substance to it A certain concentration (1 ~ 50mg/L), and add the same volume of chloroform:methanol mixture as the bacterial solution (chloroform and methanol are mixed at a volume ratio of 2:1), fully shake, and centrifuge (refer to the centrifugation condition 4°C, centrifugal force 8000×g , 15 min) and then remove the lower organic phase and blow dry, add 200-500 μL chromatographically pure n-hexane to dissolve the residual oil phase, centrifuge, transfer the supernatant to a chromatographic sampling bottle and use GC-MS to detect the aliphatic hydrocarbon content in the sample. Reference chromatographic detection conditions: Gas chromatography-mass spectrometry (GC-MS) detection uses Agilent7890A-5975C HP-INNOWax (30m×250μm×0.25μm) chromatographic column, using helium as the carrier gas, and the steady flow rate is 1mL/min . The inlet temperature was 250°C, the air flow ratio was 20:1, and the heating program was: keep the temperature at 100°C for 1 min, then raise the temperature to 150°C at 5°C/min, then raise the temperature to 250°C at 10°C/min, and keep the temperature for 15 min.
结果如图2所示,作为内标物的正二十烷出峰时间约为28min,通过与阴性对照(不携带脂肪烃途径的大肠杆菌)比较,可以发现通过AAR-ADO产烃途径合成的正十五烷和十七烯分别在大约17min和22min出峰,根据两种脂肪烃与内标物各自峰面积和分子量可以计算出合成脂肪烃的含量。但由于检测过程需要较长的时间,且脂肪烃的抽提过程步骤较复杂,仅通过有机溶剂抽提和GC-MS方法无法实现对产脂肪烃样品的快速分析和高通量筛选。The results are shown in Figure 2, the n-eicosane peak eluting time as internal standard is about 28min, by comparing with negative control (E. The peaks of n-pentadecane and heptadecene erupt at about 17min and 22min respectively, and the content of synthetic aliphatic hydrocarbons can be calculated according to the respective peak areas and molecular weights of the two aliphatic hydrocarbons and the internal standard. However, because the detection process takes a long time and the extraction process of aliphatic hydrocarbons is complicated, only organic solvent extraction and GC-MS methods cannot achieve rapid analysis and high-throughput screening of aliphatic hydrocarbon-producing samples.
实施例2利用脂肪烃元件检测细胞中脂肪烃合成Example 2 Using aliphatic hydrocarbon components to detect the synthesis of aliphatic hydrocarbons in cells
菌株:Strains:
大肠杆菌BL21(DE3)ΔfadE;大肠杆菌DH5αEscherichia coli BL21(DE3)ΔfadE; Escherichia coli DH5α
载体:Carrier:
携带脂肪醛脱甲酰加氧酶ADO和脂酰ACP还原酶AAR的质粒1:pACYCduet-ADO-AAR;携带脂肪烃检测元件AlkR-PalkM:∶GFP的质粒2(图3):pCom8-AlkR-PalkM:∶GFPPlasmid 1 carrying fatty aldehyde deformyloxygenase ADO and fatty acyl-ACP reductase AAR: pACYCduet-ADO-AAR; plasmid 2 carrying aliphatic hydrocarbon detection element AlkR-PalkM::GFP (Figure 3): pCom8-AlkR- PalkM::GFP
培养基:Medium:
LB培养基(含胰蛋白胨10g/L,酵母浸膏粉5g/L,NaCl10g/L,若为固体培养基,则每升培养基添加琼脂15g/L)LB medium (containing tryptone 10g/L, yeast extract powder 5g/L, NaCl10g/L, if it is a solid medium, add agar 15g/L per liter of medium)
改良M9培养基(含6g/LNa2HPO4,3g/LKH2PO4,0.5g/LNaCl,2g/LNH4Cl,0.25g/LMgSO4·7H2O,11mg/LCaCl2,27mg/LFeCl3·6H2O,2mg/LZnCl2·4H2O,2mg/LNa2MoO4·2H2O,1.9mg/LCuSO4·5H2O,0.5mg/LH3BO3,1mg/L维生素B1,200mMBis-Tris(pH7.25)和0.1%(v/v)Triton-X100)Improved M9 medium (containing 6g/LNa 2 HPO 4 , 3g/LKH 2 PO 4 , 0.5g/LNaCl, 2g/LNH 4 Cl, 0.25g/LMgSO 4 7H 2 O, 11mg/LCaCl 2 , 27mg/LFeCl 3 6H 2 O, 2mg/LZnCl 2 4H 2 O, 2mg/LNa 2 MoO 4 2H 2 O, 1.9mg/LCuSO 4 5H 2 O, 0.5mg/LH 3 BO 3 , 1mg/L vitamin B1, 200mMBis -Tris (pH7.25) and 0.1% (v/v) Triton-X100)
实施步骤:将质粒1和质粒2分别或共同转化大肠杆菌BL21(DE3)ΔfadE,将获得的转化子在抗性LB培养基(含34μg/mL氯霉素和/或50μg/mL庆大霉素,视携带质粒而定)中过夜培养后,转接至相应抗性的改良M9培养基,培养至对数期(OD600≈0.6-0.8)后,加入0.05~1mMIPTG诱导产烃基因表达,继续培养约10小时至20小时后,用酶标仪(带荧光模块)(或荧光显微镜、流式细胞仪)检测菌液荧光。并参照实施例1中的方法,用GC-MS方法检测样品中的脂肪烃含量Implementation steps: Plasmid 1 and plasmid 2 are transformed into Escherichia coli BL21 (DE3) ΔfadE respectively or jointly, and the transformants obtained are grown in resistant LB medium (containing 34 μg/mL chloramphenicol and/or 50 μg/mL gentamicin , depending on the plasmid carried), after overnight culture, transfer to the corresponding resistant modified M9 medium, culture to the logarithmic phase (OD600≈0.6-0.8), add 0.05~1mMIPTG to induce the expression of hydrocarbon-producing genes, and continue to culture After about 10 hours to 20 hours, use a microplate reader (with a fluorescence module) (or fluorescence microscope, flow cytometer) to detect the fluorescence of the bacterial solution. And with reference to the method in embodiment 1, detect the aliphatic hydrocarbon content in the sample with GC-MS method
结果如图4所示,同时携带质粒1和质粒2的转化子在加入IPTG并培养约10-20h后,荧光显著增强,并且荧光强度与诱导剂和脂肪烃含量呈正相关性,表明可以通过比较细胞荧光强度来间接检测脂肪烃的相对含量。The results are shown in Figure 4, the fluorescence of transformants carrying both plasmid 1 and plasmid 2 was significantly enhanced after adding IPTG and cultured for about 10-20 hours, and the fluorescence intensity was positively correlated with the content of inducer and aliphatic hydrocarbons, indicating that the Cell fluorescence intensity to indirectly detect the relative content of aliphatic hydrocarbons.
实施例3具有高产脂肪烃能力ADO突变基因的高通量筛选Example 3 High-throughput screening of ADO mutant genes with high aliphatic hydrocarbon production ability
利用引物ADO-For和ADO-Rev扩增ADO基因,并采用易错PCR反应体系以引入随机碱基突变。所用引物序列如下(划线部分为酶切位点):The ADO gene was amplified with primers ADO-For and ADO-Rev, and an error-prone PCR reaction system was used to introduce random base mutations. The primer sequences used are as follows (the underlined part is the restriction site):
ADO-For:TATACCATGGCGCAGCTTGAAGCCAGCCTADO-For: TATA CCATGG CGCAGCTTGAAGCCAGCCT
ADO-Rev:CCTGGAATTCAAACGGCCGCAAADO-Rev: CCTG GAATTC AAACGGCCGCAA
具体的,PCR反应以携带ADO基因的质粒为模板、分别采用ADO-For和ADO-Rev为上下游引物,使用Takara公司的rTaqDNA聚合酶。反应体系如下表所示:Specifically, in the PCR reaction, the plasmid carrying the ADO gene was used as a template, ADO-For and ADO-Rev were used as upstream and downstream primers respectively, and rTaqDNA polymerase from Takara Company was used. The reaction system is shown in the table below:
表1PCR反应体系Table 1 PCR reaction system
PCR反应条件为:先95℃2min;然后94℃1min,55℃1min,72℃1min,共30个循环;最后72℃10min。The PCR reaction conditions are as follows: first 95°C for 2min; then 94°C for 1min, 55°C for 1min, 72°C for 1min, a total of 30 cycles; finally 72°C for 10min.
反应结束后,对PCR扩增产物进行琼脂糖凝胶电泳(琼脂糖浓度0.8%)检测,获得约700bp的条带。将易错PCR获得的ADO基因片段用限制性内切酶NcoI和EcoRI双切,连入同样双酶切处理的质粒2(较长片段)以替换野生型ADO片段,将连接产物转化携带质粒1的宿主菌株大肠杆菌BL21(DE3)ΔfadE感受态细胞;向200μL转化产物中加入约1mLLB培养基,温育约1小时后,加入庆大霉素和氯霉素(浓度均为50μg/mL,下同);继续过夜培养后,按1:20转接至带有抗性的改良M9培养基,37℃培养至对数期(OD600≈0.6),加入0.05mMIPTG,30℃培养约16小时后,将菌液稀释至约10-6细胞/mL,利用带有分选装置的流式分选仪(如BDFACSAriaIII)进行分选(激发光485nm,发射光535nm),收集其中荧光强度最强的1%细胞(图6)。将收集的细胞涂布于带相应抗性的LB平板,温育培养,待菌落长出后,挑取单克隆接种至带有抗性LB培养基的离心管中,过夜培养后,转接至抗性的改良M9培养基,培养至对数期后,加入IPTG,继续培养10-20小时,用荧光显微镜、和酶标仪(带荧光模块)检验细胞荧光,通过比较荧光强度,获得3个突变株,分别记为突变体I,II,III,通过测序确定其中ADO突变体的氨基酸序列分别如SEQIDNO.2、SEQIDNO.3和SEQIDNO.4所示。After the reaction, the PCR amplification product was detected by agarose gel electrophoresis (0.8% agarose concentration), and a band of about 700 bp was obtained. Double-cut the ADO gene fragment obtained by error-prone PCR with restriction endonucleases NcoI and EcoRI, and connect it into the same double-digested plasmid 2 (longer fragment) to replace the wild-type ADO fragment, and transform the ligated product into carrying plasmid 1 The host strain Escherichia coli BL21(DE3)ΔfadE competent cells; add about 1mL LB medium to 200μL transformation product, after incubation for about 1 hour, add gentamicin and chloramphenicol (concentrations are both 50μg/mL, the following same); after continuing to culture overnight, transfer to the modified M9 medium with resistance at a ratio of 1:20, culture to logarithmic phase (OD600≈0.6) at 37°C, add 0.05mMIPTG, and culture at 30°C for about 16 hours, Dilute the bacterial solution to about 10 -6 cells/mL, and use a flow sorter (such as BDFACSAriaIII) with a sorting device to sort (excitation light 485nm, emission light 535nm), and collect the 1 with the strongest fluorescence intensity. % cells (Figure 6). Spread the collected cells on the LB plate with corresponding resistance, incubate and culture, after the colony grows, pick a single clone and inoculate it into a centrifuge tube with resistant LB medium, after overnight culture, transfer to The resistant modified M9 medium was cultivated to the logarithmic phase, then added IPTG, continued to cultivate for 10-20 hours, and checked the fluorescence of the cells with a fluorescence microscope and a microplate reader (with a fluorescence module). By comparing the fluorescence intensities, three cells were obtained. The mutant strains are respectively designated as mutants I, II, and III, and the amino acid sequences of the ADO mutants are determined by sequencing as shown in SEQ ID NO.2, SEQ ID NO.3 and SEQ ID NO.4.
实施例4利用ADO突变体生物合成脂肪烃Embodiment 4 utilizes ADO mutant to biosynthesize aliphatic hydrocarbon
将携带实施例3所述3种ADO突变体基因的质粒2(ADO突变体基因替换质粒2中的野生型ADO基因片段)分别克隆至产烃宿主大肠杆菌BL21(DE3)ΔfadE中;此外,为进一步提高突变体的潜在产烃能力,参考突变体3-3,将5-7突变体氨基酸序列中的194位谷氨酸替换为亮氨酸(E194K),记为突变体IV:E9G&I27N&E194K。将上述质粒转化产烃宿主大肠杆菌BL21(DE3)ΔfadE所获得的转化子参考实施例1所述培养条件和脂肪烃检测方法,测定携带所述四种突变体的菌株产烃量并与野生型ADO进行比较。Plasmid 2 carrying the three ADO mutant genes described in Example 3 (the ADO mutant gene replacing the wild-type ADO gene fragment in plasmid 2) was respectively cloned into the hydrocarbon-producing host Escherichia coli BL21(DE3)ΔfadE; in addition, for To further improve the potential hydrocarbon production capacity of the mutant, refer to mutant 3-3, replace glutamic acid at position 194 in the amino acid sequence of mutant 5-7 with leucine (E194K), and record it as mutant IV: E9G&I27N&E194K. Transform the above plasmid into the hydrocarbon-producing host Escherichia coli BL21(DE3)ΔfadE and obtain the transformants with reference to the culture conditions and aliphatic hydrocarbon detection method described in Example 1, measure the hydrocarbon production of the strains carrying the four mutants and compare with the wild-type ADO for comparison.
如图7所示,在所采用的相同培养条件下进行平行实验,携带所述四种脂肪醛脱甲酰加氧酶突变体I(3-3,E194K,SEQIDNO.2)、II(5-3,E9G&I27N,SEQIDNO.3)、III(5-7,I204F,SEQIDNO.4)、IV(3-3/5-3,E9G&I27N&E194K,SEQIDNO.5)的大肠杆菌,其烃产量分别是野生型ADO的2.0至2.9倍,表明所述四个突变体较野生型ADO具有更高的产烃效率。所述突变位点在此前没有报道。As shown in Figure 7, parallel experiments were carried out under the same culture conditions adopted, carrying the four fatty aldehyde deformyloxygenase mutants I (3-3, E194K, SEQ ID NO.2), II (5- 3, Escherichia coli of E9G&I27N, SEQIDNO.3), III (5-7, I204F, SEQIDNO.4), IV (3-3/5-3, E9G&I27N&E194K, SEQIDNO.5), the hydrocarbon production is wild-type ADO 2.0 to 2.9 times of that of ADO, indicating that the four mutants have higher hydrocarbon production efficiency than wild-type ADO. The mutation site has not been reported before.
虽然本发明已以较佳的实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明精神和范围内,都可以做各种的改动与修饰,因此,本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Any person familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore Therefore, the protection scope of the present invention should be defined by the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610183720.5A CN105802983B (en) | 2016-03-28 | 2016-03-28 | A high-throughput screening method for aliphatic hydrocarbon-producing genes and the obtained mutants and applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610183720.5A CN105802983B (en) | 2016-03-28 | 2016-03-28 | A high-throughput screening method for aliphatic hydrocarbon-producing genes and the obtained mutants and applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105802983A true CN105802983A (en) | 2016-07-27 |
CN105802983B CN105802983B (en) | 2019-12-03 |
Family
ID=56454886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610183720.5A Active CN105802983B (en) | 2016-03-28 | 2016-03-28 | A high-throughput screening method for aliphatic hydrocarbon-producing genes and the obtained mutants and applications |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105802983B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108342407A (en) * | 2018-03-07 | 2018-07-31 | 江南大学 | A method of obtain high expression, high vigor and high stability enzyme mutant |
CN108753912A (en) * | 2018-06-25 | 2018-11-06 | 江南大学 | A kind of high-throughput screening method of trans-anethole oxygenation enzyme mutant and mutant strain and mutant |
CN109486835A (en) * | 2018-12-05 | 2019-03-19 | 中国科学院合肥物质科学研究院 | It is a kind of derived from the production alkane key gene muton of cyanobacteria and its application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1065092A (en) * | 1990-09-24 | 1992-10-07 | 综合医院公司 | Screening Assays |
CN1778919A (en) * | 2005-09-30 | 2006-05-31 | 东北师范大学遗传与细胞研究所 | A human MDR1 gene expression regulator screening system and method for screening gene expression regulator |
US20080293060A1 (en) * | 2007-04-23 | 2008-11-27 | Ls9, Inc. | Methods and Compositions for Identification of Hydrocarbon Response, Transport and Biosynthesis Genes |
-
2016
- 2016-03-28 CN CN201610183720.5A patent/CN105802983B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1065092A (en) * | 1990-09-24 | 1992-10-07 | 综合医院公司 | Screening Assays |
CN1778919A (en) * | 2005-09-30 | 2006-05-31 | 东北师范大学遗传与细胞研究所 | A human MDR1 gene expression regulator screening system and method for screening gene expression regulator |
US20080293060A1 (en) * | 2007-04-23 | 2008-11-27 | Ls9, Inc. | Methods and Compositions for Identification of Hydrocarbon Response, Transport and Biosynthesis Genes |
Non-Patent Citations (1)
Title |
---|
姚文兵: "《生物技术制药概论》", 31 December 2010 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108342407A (en) * | 2018-03-07 | 2018-07-31 | 江南大学 | A method of obtain high expression, high vigor and high stability enzyme mutant |
CN110295159A (en) * | 2018-03-07 | 2019-10-01 | 江南大学 | A kind of enzyme mutant |
CN110358786A (en) * | 2018-03-07 | 2019-10-22 | 江南大学 | A kind of enzyme mutant |
CN110373404A (en) * | 2018-03-07 | 2019-10-25 | 江南大学 | A kind of enzyme mutant |
CN110373404B (en) * | 2018-03-07 | 2021-11-16 | 江南大学 | Enzyme mutant |
CN110358786B (en) * | 2018-03-07 | 2022-02-01 | 江南大学 | Enzyme mutant |
CN108753912A (en) * | 2018-06-25 | 2018-11-06 | 江南大学 | A kind of high-throughput screening method of trans-anethole oxygenation enzyme mutant and mutant strain and mutant |
CN108753912B (en) * | 2018-06-25 | 2021-08-24 | 江南大学 | A high-throughput screening method for trans-anethole oxygenase mutants and mutant strains and mutants |
CN109486835A (en) * | 2018-12-05 | 2019-03-19 | 中国科学院合肥物质科学研究院 | It is a kind of derived from the production alkane key gene muton of cyanobacteria and its application |
CN109486835B (en) * | 2018-12-05 | 2022-02-11 | 中国科学院合肥物质科学研究院 | A cyanobacteria-derived key gene mutant for alkane production and its application |
Also Published As
Publication number | Publication date |
---|---|
CN105802983B (en) | 2019-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gao et al. | Photosynthetic production of ethanol from carbon dioxide in genetically engineered cyanobacteria | |
Zhu et al. | Coproduction of acetaldehyde and hydrogen during glucose fermentation by Escherichia coli | |
McAnulty et al. | Metabolic engineering of Methanosarcina acetivorans for lactate production from methane | |
CN102876706B (en) | Method for high-throughput screening recombinant trichoderma reesei for efficiently expressing foreign protein | |
US10837036B2 (en) | Method for preparing L-aspartic acid with maleic acid by whole-cell biocatalysis | |
CN105802983B (en) | A high-throughput screening method for aliphatic hydrocarbon-producing genes and the obtained mutants and applications | |
CN107142287B (en) | Application of artemisinaldehyde double bond reductase DBR1 and its recombinant bacteria in the preparation of dihydro-β-ionone | |
US20230183627A1 (en) | Biomanufacturing systems and methods for producing organic products from recombinant microorganisms | |
CN112961791A (en) | Recombinant strain of non-specific peroxygenase and construction method and application thereof | |
CN109777788B (en) | A leucine dehydrogenase mutant and its application | |
CN105255951B (en) | A method of Alcohol Production efficiency is improved by overexpression HAC1 genes | |
CN110615832A (en) | Bmor mutant for efficiently screening isobutanol high-yield strains | |
CN112175919A (en) | Lactone hydrolase mutant and application thereof | |
CN105463005B (en) | Construct for detecting aliphatic hydrocarbon in microbial cell and method for detecting aliphatic hydrocarbon in situ by using construct | |
CN114107155B (en) | Medium-long chain alkane induction type biosensor and application thereof | |
CN109486835B (en) | A cyanobacteria-derived key gene mutant for alkane production and its application | |
CN105255952B (en) | A method of Alcohol Production efficiency is improved by overexpression INO2 genes | |
CN112941003A (en) | Method for synthesizing L-alanine by catalyzing maleic acid through double-enzyme coupling whole cells | |
CN101418295B (en) | Biosensor and use thereof | |
CN113223616A (en) | Method for screening salt-adapted PL7 family alginate lyase | |
CN111321098B (en) | A kind of Escherichia coli genetically engineered bacteria with high tolerance to sachinene and its construction method and application | |
CN114107285B (en) | A method to use alkane sensors to evolve hydrocarbon-producing enzymes to produce long-chain alkanes | |
CN114317585B (en) | Liquid drop microfluidic assisted method for screening double rhamnolipid high-yield strain | |
CN111254143A (en) | Construction method, strain and application of Arthrobacter simplex engineering strain with excellent stress tolerance | |
CN119331063A (en) | Isobutyraldehyde biosensor and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |